WIGAL, TIM
43  Ergebnisse:
Personensuche X
?
1

Safety and Efficacy of Centanafadine Sustained-Release in A..:

Wigal, Sharon B. ; Wigal, Tim ; Hobart, Mary...
Neuropsychiatric Disease and Treatment.  16 (2020)  - p. 1411-1426 , 2020
 
?
3

The Time Course of Effect of Multilayer-Release Methylpheni..:

Wigal, Sharon B. ; Wigal, Tim ; Childress, Ann..
Journal of Attention Disorders.  24 (2016)  3 - p. 373-383 , 2016
 
?
5

The Biopharmaceutics Risk Assessment Roadmap for Optimizing..:

Selen, Arzu ; Dickinson, Paul A. ; Müllertz, Anette...
Journal of Pharmaceutical Sciences.  103 (2014)  11 - p. 3377-3397 , 2014
 
?
 
?
9

Stimulant-Related Reductions of Growth Rates in the PATS:

SWANSON, JAMES ; GREENHILL, LAURENCE ; WIGAL, TIM...
Journal of the American Academy of Child & Adolescent Psychiatry.  45 (2006)  11 - p. 1304-1313 , 2006
 
?
10

Safety and Tolerability of Methylphenidate in Preschool Chi..:

WIGAL, TIM ; GREENHILL, LAURENCE ; CHUANG, SHIRLEY...
Journal of the American Academy of Child & Adolescent Psychiatry.  45 (2006)  11 - p. 1294-1303 , 2006
 
?
13

Acknowledgements:

, In: Therapist's Guide to Learning and Attention Disorders,
Crinella, Frank ; Deich, Ruth ; Eastman, Cheryl... - p. xxiii , 2003
 
?
14

Traditional and Innovative Assessment of Children with Atte..:

, In: Therapist's Guide to Learning and Attention Disorders,
 
?
15

Carbamazepine reduces dopamine-mediated behavior in chronic..:

LaHoste, Gerald J. ; Wigal, Tim ; King, Bryan H....
Experimental and Clinical Psychopharmacology.  8 (2000)  1 - p. 125-132 , 2000
 
1-15